Histone Acetyl Transferase 1 Is Overexpressed in Poor Prognosis, High-grade Meningeal and Glial Brain Cancers: Immunohistochemical and Aptahistochemical Study
- 24 August 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 72 (8-9) , 585-599
Abstract
Primary malignancies of the central nervous system account for 2% of all cancers in adults and almost 15% in children under 15 years of age. The prognosis of brain anaplastic cancers and glioblastomas remains extremely poor, with devastating survival expectative, and new molecular markers and therapeutic targets are essential. Epigenetic changes constitute an extensive field for the development of new diagnostic and therapeutic strategies. Histone acetyl transferase-1 (HAT1) has merged as a potential prognostic marker and therapy target for different malignancies. Data repository analysis showed HAT1 mRNA overexpression in gliomas and has been described its alternative splicing in glioblastomas. Using immunohistochemical and aptahistochemical methods, we analyzed the expression of HAT1 in meningiomas, oligodendrogliomas, and astroglial cancers. We observed that HAT1 overexpression is associated with the most aggressive tumor types and the worse prognosis, as well as with a higher probability of early relapse in meningiomas. Its cytosolic localization correlates with tumor progression and prognosis. Aptamers, synthetic oligonucleotides capable to bind and inhibit a wide variety of targets, are considered as promising diagnostic and therapeutic tools. Aptahistochemistry using the aptamer apHAT610 offered superior results in comparison with the antibody used, as a good example of the potential of aptamers as diagnostic tools for histopathology.Keywords
Funding Information
- Inari Biotech S.L./ Programa Investigo, Comunidad de Madrid-NextGenerationEU
- Inari Biotech S.L./Programa Investigo, Comunidad de Madrid-NextGenerationEU
This publication has 46 references indexed in Scilit:
- Histone acetyltransferase 1 (HAT1) acetylates hypoxia-inducible factor 2 alpha (HIF2A) to execute hypoxia responseBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2022
- Patients’ Survival with Astrocytoma After Treatment: a Systematic Review and Meta-analysis of Clinical Trial StudiesIndian Journal of Surgical Oncology, 2022
- Tumor Development and Angiogenesis in Adult Brain Tumor: GlioblastomaMolecular Neurobiology, 2020
- Incidence, mortality and outcome of meningiomas: A population-based study from GermanyCancer Epidemiology, 2019
- RNA Aptamers Targeting Integrin α5β1 as Probes for Cyto- and Histofluorescence in GlioblastomaMolecular Therapy Nucleic Acids, 2019
- Histone Acetyltransferase 1 Links Metabolism and Transcription to Cell-Cycle ProgressionMolecular Cell, 2019
- Aptamer-guided nanomedicines for anticancer drug deliveryAdvanced Drug Delivery Reviews, 2018
- Therapeutic aptamers in discovery, preclinical and clinical stagesAdvanced Drug Delivery Reviews, 2018
- Aptahistochemistry in diagnostic pathology: technical scrutiny and feasibilityHistochemistry and Cell Biology, 2017
- Application of Aptamers in Histopathology2016